Applied BioCode Corp
TWSE:6598
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Johor Plantations Group Bhd
KLSE:JPG
|
MY |
Applied BioCode Corp
Cash from Operating Activities
Applied BioCode Corp
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Applied BioCode Corp
TWSE:6598
|
Cash from Operating Activities
-NT$226.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medimaging Integrated Solution Inc
TWSE:6796
|
Cash from Operating Activities
-NT$50.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Bionime Corp
TWSE:4737
|
Cash from Operating Activities
NT$288m
|
CAGR 3-Years
47%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
Apex Biotechnology Corp
TWSE:1733
|
Cash from Operating Activities
NT$160.1m
|
CAGR 3-Years
82%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-10%
|
|
|
Wellell Inc
TWSE:4106
|
Cash from Operating Activities
NT$207.5m
|
CAGR 3-Years
36%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
Applied BioCode Corp
Glance View
Applied BioCode Corp. designs, develops, manufactures and commercializes multiplex testing products for in-vitro diagnostics market. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-02-09. The firm's main products include digital barcode magnetic beads (BMB), optical analyzers, in vitro diagnostic reagents and others. The firm sells in the United States, Europe and Asia markets.
See Also
What is Applied BioCode Corp's Cash from Operating Activities?
Cash from Operating Activities
-226.6m
TWD
Based on the financial report for Dec 31, 2025, Applied BioCode Corp's Cash from Operating Activities amounts to -226.6m TWD.
What is Applied BioCode Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-9%
Over the last year, the Cash from Operating Activities growth was -9%.
